Misplaced Pages

Carbutamide

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	A10BB06 (WHO)
Identifiers
IUPAC name 4-amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number	339-43-5
PubChem CID	9564
ChemSpider	9189
UNII	E3K8P4869P
ChEMBL	ChEMBL448570
CompTox Dashboard (EPA)	DTXSID8022741
ECHA InfoCard	100.005.841
Chemical and physical data
Formula	C11H17N3O3S
Molar mass	271.33 g·mol
3D model (JSmol)	Interactive image
SMILES O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
InChI InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15) Key:VDTNNGKXZGSZIP-UHFFFAOYSA-N
(what is this?)  (verify)

Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.

It is classified as first-generation.

It was patented in 1953 and approved for medical use in 1956.

See also

• Hellmuth Kleinsorge (1920-2001) German medical doctor

References

1. Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Research and Clinical Practice. 8 (2): 109–114. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.
2. Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 449. ISBN 9783527607495.

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Potassium channel blockers
• Benzenesulfonylureas
• 4-Aminophenyl compounds
• Butyl compounds
• Gastrointestinal system drug stubs